X4 Pharmaceuticals, Inc. - stock earnings
XFOR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -19.1 million USD | ? USD |
| 2023Q3 | -2.3 million USD | ? USD |
| 2023Q2 | -55.7 million USD | ? USD |
| 2023Q1 | -55.7 million USD | ? USD |
| 2022Q4 | -24.0 million USD | ? USD |
| 2022Q3 | -29.1 million USD | ? USD |
| 2022Q2 | -21.2 million USD | ? USD |
| 2022Q1 | -22.0 million USD | ? USD |
| 2021Q4 | -30.2 million USD | ? USD |
| 2021Q3 | -20.2 million USD | ? USD |
| 2021Q2 | -19.6 million USD | ? USD |
| 2021Q1 | -18.7 million USD | ? USD |
| 2020Q4 | -18.4 million USD | ? USD |
| 2020Q3 | -17.4 million USD | ? USD |
| 2020Q2 | -15.1 million USD | ? USD |
| 2020Q1 | -11.1 million USD | 3.0 million USD |
| 2019Q4 | -10.8 million USD | ? USD |
| 2019Q3 | -17.7 million USD | ? USD |
| 2019Q2 | -13.4 million USD | ? USD |
| 2019Q1 | -10.9 million USD | 3.5 million USD |
| 2018Q4 | -9.4 million USD | 3.5 million USD |
| 2018Q3 | -10.9 million USD | ? USD |
| 2018Q2 | -12.1 million USD | ? USD |
| 2018Q1 | -10.6 million USD | ? USD |
| 2017Q4 | -11.2 million USD | ? USD |
| 2017Q3 | -11.6 million USD | ? USD |
| 2017Q2 | -5.7 million USD | ? USD |
| 2017Q1 | -5.4 million USD | ? USD |
| 2016Q4 | -5.3 million USD | ? USD |
XFOR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -101.2 million USD | ? USD |
| 2022 | -93.9 million USD | ? USD |
| 2021 | -88.7 million USD | ? USD |
| 2020 | -62.1 million USD | 3.0 million USD |
| 2019 | -56.6 million USD | 3.0 million USD |
| 2018 | -43.0 million USD | 3.5 million USD |
| 2017 | -33.9 million USD | ? USD |
| 2016 | -23.0 million USD | ? USD |
| 2015 | -13.2 million USD | ? USD |
XFOR
Price: $1.10
52 week price:
Earnings Per Share: -0.57 USD
P/E Ratio: -1.35
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 471700
Market Capitalization: 221.7 million